Freeport-McMoRan Inc. (FCX) vs Ingevity Corporation (NGVT)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| FCX | NGVT | |
|---|---|---|
| Sector | Basic Materials | Basic Materials |
| Industry | Copper | Specialty Chemicals |
| Size band | LARGE | MID |
| Listing | NYSE | NYSE |
| Country | United States | United States |
| Theme | copper-mining | specialty-chemicals |
| Price and returns | ||
| Last close | $65.16 | $71.03 |
| Return · 1 week | −6.58% | +1.02% |
| Return · 1 month | −9.45% | −2.35% |
| Return · 3 months | +5.71% | −4.64% |
| Return · year to date | +26.07% | +18.21% |
| Return · 1 year | +59.29% | +26.64% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −18.79% | −10.42% |
| 52-week high | $80.24 | $79.29 |
| 52-week low | $38.54 | $45.85 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $93.60B | $2.44B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $766.61M | $16.02M |
| Employees | 29,000 | 1,400 |
| Valuation | ||
| Price to earnings · trailing | 36.30× | 99.74× |
| Price to earnings · forward | 17.09× | 11.61× |
| Price to sales | 4.09× | 2.07× |
| Price to book | 5.26× | 51.34× |
| Enterprise value to EBITDA | 12.73× | 9.50× |
| Enterprise value to revenue | 4.70× | 3.05× |
| PEG ratio | 4.54 | 2.41 |
| Earnings per share · trailing | 2.03 | 0.70 |
| Profitability | ||
| Gross margin | 27.06% | 41.13% |
| Operating margin | 33.40% | 29.90% |
| Profit margin | 11.35% | 2.17% |
| Return on equity | 14.76% | 30.07% |
| Return on assets | 7.59% | 10.41% |
| Growth | ||
| Revenue growth | −7.30% | −5.20% |
| Earnings growth | +28.10% | — |
| Balance sheet and payout | ||
| Debt / equity (%) | 32.15 | 2,636.03 |
| Current ratio | 2.07 | 1.61 |
| Dividend yield | 0.84% | 0.00% |
| Payout ratio | 29.56% | 0.00% |
| Trend and volatility | ||
| RSI · 14 | 33.74 | 52.47 |
| ADX · 14 | 17.12 | 9.74 |
| 50-day average | $71.86 | $70.26 |
| 200-day average | $65.08 | $71.08 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.76% | 2.65% |
The full FCX analysis
Everything this table leaves out for Freeport-McMoRan Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the FCX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full FCX analysisThe full NGVT analysis
Everything this table leaves out for Ingevity Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the NGVT argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full NGVT analysis